To study the regulation of proteins in TKRDF-treated postmenopausal dyslipidemia in vivo, western blot analysis was used to determine the expression of ERK1/2 (MAPK3/1), AKT, PI3K p110α (PIK3CA) and PPARγ (PPARG) in liver tissue. Here, MAPK3 is linked to metabolic syndrome.